Cargando…
Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology
CONTEXT: Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action. OBJECTIVE: Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes. MATERI...
Autores principales: | Xu, Feng, Zhang, Mei, Wu, Hongmei, Wang, Yuanmin, Yang, Ye, Wang, Xiangpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154797/ https://www.ncbi.nlm.nih.gov/pubmed/35635284 http://dx.doi.org/10.1080/13880209.2022.2067568 |
Ejemplares similares
-
RP-HPLC Characterization of Lupenone and β-Sitosterol in Rhizoma Musae and Evaluation of the Anti-Diabetic Activity of Lupenone in Diabetic Sprague-Dawley Rats
por: Xu, Feng, et al.
Publicado: (2014) -
Molecular mechanism underlying the anti-inflammatory effects of volatile components of Ligularia fischeri (Ledeb) Turcz based on network pharmacology
por: Huang, Xulong, et al.
Publicado: (2020) -
Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosoma cruzi
por: Polanco-Hernández, Glendy, et al.
Publicado: (2013) -
Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology
por: Geng, Hua, et al.
Publicado: (2021) -
Andrographolide in atherosclerosis: integrating network pharmacology and in vitro pharmacological evaluation
por: Shi, Shuai, et al.
Publicado: (2022)